Prevalence and Predictors of Hair Shedding Among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia

    January 2026 in “ Skin Appendage Disorders
    Sali Alharbi, Azzam Alkhalifah
    TLDR Hair shedding is common in GLP-1 users, affecting treatment adherence.
    A recent cross-sectional study from Saudi Arabia found that hair shedding affects 70% of GLP-1 receptor agonist users, a prevalence ten times higher than reported in registration trials. This issue notably impacts treatment adherence, especially in women experiencing significant weight loss. The study highlights the importance of proactive counseling and nutritional optimization to support continued treatment adherence.
    Discuss this study in the Community →

    Research cited in this study

    11 / 11 results